Gilead Sciences Inc, Ten Percent Owner at Achillion Pharmaceuticals, holds 1.12M shares in Achillion Pharmaceuticals (Ticker: ~ACHN), holds 13.91M shares in Arcus Biosciences (Ticker: RCUS). Most recently, Gilead Sciences Inc ― shares of Achillion Pharmaceuticals on ― for an estimated value of ―.